This study examines using metabolite profiling to detect recurrent breast cancer through nuclear magnetic resonance (NMR) and mass spectrometry (MS). These techniques are used to analyze serum samples and identify putative biomarkers, which are then validated through supervised and unsupervised methods. The supervised method determines if cancer is present, while the unsupervised method detects clusters. This metabolite profiling approach provides a more sensitive detection method than mammography and blood tests and could significantly help increase breast cancer survival rates if applied in clinical practice.